Beta Bionics, Inc. Common Stock (BBNX) — Defensive Interval Ratio
Beta Bionics, Inc. Common Stock (BBNX) has a Defensive Interval Ratio of 2946 days as of March 2026. Defensive assets of $187.20 Million (cash $-, short-term investments $169.31 Million, receivables $17.89 Million) cover 2946 days of daily cash needs of $63.54K/day. See Beta Bionics, Inc. Common Stock short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Beta Bionics, Inc. Common Stock Defensive Interval Ratio (2022–2025)
This chart shows how Beta Bionics, Inc. Common Stock's Defensive Interval Ratio has evolved across 4 annual periods from 2022 to 2025. As of March 2026, the ratio stands at 2946 days, meaning defensive assets of $187.20 Million can fund 2946 days of operations without new revenue. See how leveraged is Beta Bionics, Inc. Common Stock's balance sheet to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Beta Bionics, Inc. Common Stock (2022–2025)
The table below presents the year-by-year Defensive Interval Ratio for Beta Bionics, Inc. Common Stock from 2022 to 2025, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Beta Bionics, Inc. Common Stock market capitalisation.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 2448 days | $207.44 Million | $84.72K/day | $- | $187.55 Million | ▲ +979 days |
| 2024 | 1469 days | $85.14 Million | $57.94K/day | $- | $73.14 Million | ▼ -1099 days |
| 2023 | 2568 days | $74.63 Million | $29.05K/day | $- | $70.18 Million | ▲ +2568 days |
| 2022 | 0 days | $0.00 | $24.31K/day | $- | $0.00 | — |